BioSculpture Technology
BioSculpture Technology is a privately-held medical device company that designs, patents, and manufactures FDA-cleared Twin Cannula Assisted Liposuction (TCAL) systems and accessories for plastic and cosmetic surgeons, while developing endoscopic visceral lipectomy technology for obesity and metabolic disease treatment.
- Company typePrivate
- Founded2001
- HeadquartersWest Palm Beach, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What BioSculpture Technology does
BioSculpture Technology, Inc. is a privately-held medical device company founded in 2001 as a spin-off from Rocin Laboratories, Inc., specializing in power-assisted liposuction systems built around its proprietary Twin Cannula Assisted Liposuction (TCAL) technology. The company's flagship Airbrush Liposculptor product line uses a tube-within-a-tube design in which an inner cannula is ensheathed within a slotted outer cannula, eliminating the battering ram effect of conventional single-cannula systems, reducing surgeon fatigue, and enabling controlled removal of 10+ pounds of fat in a single outpatient procedure, with reported 30%+ reductions in operating surgical times.
The company's product portfolio includes the Airbrush Liposculptor II and III hand pieces, the Intellimotion digital signal processor controller, RadioSurgery modules, compressors, cannula sets, and an FDA-cleared Multicore Quick Connector. BioSculpture holds 23+ U.S. patents with 21 pending applications and is developing EVL (Endoscopic Visceral Lipectomy), a patented minimally invasive method targeting obesity, metabolic syndrome, and type 2 diabetes. The company sells through manufacturer representatives covering U.S. territories plus Canada, Italy, Morocco, Taiwan, and Korea, and operates a direct e-commerce storefront. Revenue is generated through one-time hardware sales, licensing royalties (including to former OEM partners NuMed, Byron Medical, and Mentor), and professional services, though the current product catalogue is listed as unavailable while production is being retooled to a next-generation electrical TCAL system.
BioSculpture Technology firmographics
Firmographics- Name
- BioSculpture Technology
- Legal name
- BioSculpture Technology, Inc.
- Website
- https://biosculpturetechnology.com
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BioSculpture Technology is a privately-held medical device company that designs, patents, and manufactures FDA-cleared Twin Cannula Assisted Liposuction (TCAL) systems and accessories for plastic and cosmetic surgeons, while developing endoscopic visceral lipectomy technology for obesity and metabolic disease treatment.
- Ownership category
- akta.pro rank
BioSculpture Technology industry classification
Industry- Product category
- Liposuction Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)
Keywords
Where BioSculpture Technology is headquartered
LocationHeadquarters
- HQ city
- West Palm Beach
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
BioSculpture Technology business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
Revenue model
- Medical Device Sales: Sale of FDA-cleared Airbrush Liposculpture systems, Intellimotion controllers, cannula sets, and accessories to plastic/cosmetic surgeons. Products include the Airbrush Liposculptor II, RadioSurgery Module, and Compressor.
- Licensing Royalties: Exclusive licensee of tissue aspiration and processing portfolio from parent company Rocin Laboratories, Inc. The company also licenses its technology to other manufacturers (NuMed, Byron Medical, Mentor).
- Regulation D Private Placement: Exempt offering of securities under Regulation D with total offering amount of $10 million for expansion and development.
- Tier 2 Regulation A Public Offering: SEC-qualified public offering terminated August 31, 2017. Offered 1,428,571 common shares at $3.50 per share to fund EVL development and commercialization.
- Professional Services: Warranty repairs, extended service contracts, and physician referral services for Airbrush-certified surgeons.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Airbrush Liposculptor II (Model LS-HP-AB-102) |
| One time/ perpetual license | Pay-as-you-go | Intellimotion Controller (Model LS-PC-BB-101) |
| One time/ perpetual license | Pay-as-you-go | Airbrush RadioSurgery Module (Model LS-EC-BB-101) |
| Unit Pricing | Pay-as-you-go | Cannula Sets (Various Models) |
| One time/ perpetual license | Pay-as-you-go | Regulation A Common Shares |
| One time/ perpetual license | Pay-as-you-go | Airbrush Compressor (Model LS-AC-BB-101) |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
BioSculpture Technology product offering
Product offeringCore offering
BioSculpture Technology designs, manufactures, and sells FDA-cleared power-assisted liposuction medical devices for plastic and cosmetic surgeons. Its core offering is the Airbrush Liposculptor family built on proprietary Twin Cannula Assisted Liposuction (TCAL) technology, paired with the Intellimotion digital controller and a line of disposable cannula sets and accessories. The company is also developing the Endoscopic Visceral Lipectomy (EVL) system for visceral fat removal targeting the obesity market.
Product overview
BioSculpture Technology offers a modular system of medical devices for power-assisted liposuction and body sculpting. The core product line centers on the Airbrush® Liposculpture system, which includes the twin-cannula assisted liposuction (TCAL) hand pieces (Airbrush® Liposculptor, II, III, and IIE variants), supported by the Intellimotion® Controller, specialized cannula sets, and accessories including the RadioSurgery Module and Compressor. The company also provides Multicore Quick Connectors for integrated connectivity and is developing EVL (Endoscopic Visceral Lipectomy) technology for visceral fat removal as a treatment for obesity and metabolic conditions. The products range from FDA-cleared commercial devices to products in various stages of development.
Differentiator
Problem solved
Functional benefit
Brands
- Airbrush Liposculpture: Twin Cannula Assisted Liposuction (TCAL) power-assisted liposuction system for body sculpting procedures
- Intellimotion
- EVL (Endoscopic Visceral Lipectomy)
Products and services
- Airbrush Liposculptor (original) Power-assisted liposuction capital system using Twin Cannula Assisted Liposuction (TCAL) technology, used by plastic and cosmetic surgeons for fat extraction and body contouring.
- Airbrush Liposculptor II Second-generation power-assisted liposuction device with Twin Cannula Assisted Liposuction technology and FDA 510(k) clearance, targeted at plastic and cosmetic surgeons and surgical hospitals.
- Airbrush Liposculptor III Latest-generation Airbrush Liposculptor power-assisted liposuction system, integrating the Twin Cannula Assisted Liposuction (TCAL) architecture and Intellimotion controller, used by plastic and cosmetic surgeons for fat extraction and body contouring.
- Intellimotion Controller Digital controller for the Airbrush Liposculptor family that regulates Twin Cannula Assisted Liposuction motion and procedure parameters, providing digital signal processing control of the liposuction device.
- Cannula Sets (disposable) Disposable Twin Cannula Assisted Liposuction cannula sets used as per-procedure consumables with the Airbrush Liposculptor system, sold to surgical practices and hospitals.
- Multicore Quick Connector Multi-line quick connector accessory for the Airbrush Liposculptor system that enables rapid, integrated connection of cannulas and tubing during liposuction procedures.
- RadioSurgery Module RadioSurgery accessory module for the Airbrush Liposculptor system that adds electrosurgical capability to liposuction procedures performed by plastic and cosmetic surgeons.
- Airbrush Compressor Compressor accessory that supplies pneumatic drive for the Airbrush Liposculptor system, completing the Twin Cannula Assisted Liposuction (TCAL) hardware offering for surgical practices.
- Endoscopic Visceral Lipectomy (EVL) In-development endoscopic visceral lipectomy device extending BioSculpture's Twin Cannula Assisted Liposuction (TCAL) technology to removal of visceral fat for obesity treatment, intended for use by surgeons and bariatric specialists.
Quantifiable outcome
- 30%+ reduction in operating surgical times
- +2 more outcomes
Companies that use BioSculpture Technology
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles2 records
BioSculpture Technology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
BioSculpture Technology partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- NuMed (Power Cannula)minorLicensed technology to NuMed for distribution of Power Cannula - a reusable unit powered by a small hand-held low voltage electrical motor. Nu-Med distributed the device as Byron Medical acquired Mentor which was acquired by Ethicon.
- Byron MedicalminorLicensed ARC (Systems Reciprocating Cannula) technology to Byron Medical. Manufacturing disposable gas-powered assembly driven by vacuum system for Psi-Tec Systems Aspiration Platform. Byron Medical was subsequently acquired by Mentor.
- MentorminorAcquired Byron Medical and continued distribution of powered liposuction technology. Subsequently acquired by Ethicon, creating a major medical device conglomerate pathway for the technology.
- Rocin Laboratories, Inc.coreParent company and IP source. BioSculpture Technology was created as an independent company to exclusively license the tissue aspiration and processing portfolio from Rocin Laboratories. Rocin was founded by Dr. Cucin 20 years ago and maintains a worldwide patent portfolio including Skin Care Division, Rocin Press, Lipotome Systems, and Surgical Tools Division.
- SNNLive / WestPark CapitalminorMedia coverage and interview partnerships at investment conferences. SNNLive conducted video interviews with CEO Dr. Robert Cucin during Media Day 2016 at WestPark Capital in New York City.
- CEO ClipsminorDocumentary series profiling innovative publicly traded companies in North America featured BioSculpture Technology on The Documentary Channel July 3-16, 2017.
Scale indicators10 records
Recent moves10 records
Expansion highlights6 records
BioSculpture Technology competitors and assessment
Company assessmentDirect peers
- MicroAire Surgical Instruments: Direct competitor in power-assisted liposuction (PAL) systems. MicroAire's PAL device competes head-to-head against BioSculpture's TCAL technology for the same plastic surgeon customers performing body contouring procedures.
- Wells Johnson Company: Long-established manufacturer of power-assisted liposuction equipment and tumescent infiltration systems serving the same plastic and cosmetic surgeon customer base as BioSculpture.
- Solta Medical (Bausch Health): Markets VASERlipo, an ultrasound-assisted liposuction system directly competitive with BioSculpture's TCAL, and also offers non-invasive body contouring platforms (Liposonix, Thermage) addressing adjacent demand.
Broad incumbents
- Mentor (Ethicon, Johnson & Johnson MedTech): Previously licensed BioSculpture/Byron Medical's ARC powered-liposuction technology and now operates inside J&J's MedTech platform. Competes broadly across aesthetic surgery and leverages vastly greater commercial and R&D resources.
- InMode: Public aesthetic medical device company offering BodyTite, Morpheus8, and related body contouring/liposuction platforms. Competes for the same plastic surgeon budgets and accounts with broader minimally invasive product lines.
- Cynosure (Hologic): Aesthetic medical device platform within Hologic covering laser- and RF-based body contouring systems. Targets the same cosmetic surgery customer base as BioSculpture, though via non-powered-liposuction modalities.
- Alma Lasers: Global aesthetic device manufacturer offering laser- and RF-assisted body contouring and lipolysis systems (e.g., Accent, BeautiFill). Targets the same plastic/cosmetic surgery segment as BioSculpture with broader modality coverage.
Emerging players
- Apyx Medical: Markets Renuvion (J-Plasma) for subdermal tissue coagulation in body contouring procedures. Competes for share of cosmetic surgery workflows that might otherwise use powered liposuction systems like BioSculpture's TCAL.
- AbbVie (Allergan Aesthetics / CoolSculpting): CoolSculpting represents a non-invasive cryolipolysis alternative that diverts demand away from powered liposuction procedures. Relevant peer as the dominant non-surgical body contouring modality competing for the same patient population.
Regional players
- Human Med (Wasserstrahl-Technik): German manufacturer of water-jet assisted liposuction (WAL) systems competing with BioSculpture in the powered-liposuction category. Operates primarily in Europe with limited direct US presence.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
BioSculpture Technology social profiles
Digital presenceBioSculpture Technology compliance and trust
Trust signalCompliance3 records
BioSculpture Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioSculpture Technology leadership team
Management profileNumber of profiles
Profiles9 records
BioSculpture Technology funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioSculpture Technology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioSculpture Technology
What does BioSculpture Technology do?
BioSculpture Technology designs, manufactures, and sells FDA-cleared power-assisted liposuction medical devices for plastic and cosmetic surgeons. Its core offering is the Airbrush Liposculptor family built on proprietary Twin Cannula Assisted Liposuction (TCAL) technology, paired with the Intellimotion digital controller and a line of disposable cannula sets and accessories. The company is also developing the Endoscopic Visceral Lipectomy (EVL) system for visceral fat removal targeting the obesity market.
Is BioSculpture Technology a public or private company?
BioSculpture Technology is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BioSculpture Technology founded?
BioSculpture Technology was founded in 2001. It employs 11 to 50 people.
Where is BioSculpture Technology based?
BioSculpture Technology is headquartered in West Palm Beach, United States, in the North America region.
How does BioSculpture Technology make money?
Five revenue lines are on record. Medical Device Sales are the primary driver. The others are licensing Royalties, regulation D Private Placement, tier 2 Regulation A Public Offering and professional Services.
Who are BioSculpture Technology's main competitors?
Direct peers on record are MicroAire Surgical Instruments, Wells Johnson Company and Solta Medical (Bausch Health). Broad incumbents are Mentor (Ethicon, Johnson & Johnson MedTech), InMode, Cynosure (Hologic) and Alma Lasers. Emerging players are Apyx Medical and AbbVie (Allergan Aesthetics / CoolSculpting). Human Med (Wasserstrahl-Technik) is listed as a regional player.
Does BioSculpture Technology have an API?
No public API is recorded for BioSculpture Technology.
What industry is BioSculpture Technology in?
BioSculpture Technology's product category is Liposuction Medical Devices. Its primary akta.pro industry code is HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools). Its NAICS code is 334510 and its SIC code is 3841.